Industry Research Reports
Home > Reports > Service & Software > Global Respiratory Panel Testing Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Respiratory Panel Testing Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Service & Software
Published Date: 2025-11-16
Pages: 132 Pages
Report ld: 5453594
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global Respiratory Panel Testing market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Respiratory Panel Testing market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- F. Hoffmann-La Roche Ltd.
- bioMerieux SA
- Medline Industries, Inc.
- Becton
- Dickinson & Company
- altona Diagnostics GmbH
- CerTest Biotec S.L.
- Anatolia Geneworks
- Seegene, Inc.
- DiaSorin S.p.A. (Luminex)
- QIAGEN
- Biocartis
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Adenovirus
- RSV
- Human Metapneumovirus
- Rhinovirus/Enterovirus
- Flu A
- Coronavirus
- Flu B
- Others
Segment by Application
- Point-of-Care Testing
- Laboratories
- Hospitals
- Others
CHAPTER OUTLINE
Chapter 1: Defines the Respiratory Panel Testing study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; top-tier players 2024 sales breakdowns by product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Respiratory Panel Testing: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Respiratory Panel Testing Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Adenovirus
1.2.3 RSV
1.2.4 Human Metapneumovirus
1.2.5 Rhinovirus/Enterovirus
1.2.6 Flu A
1.2.7 Coronavirus
1.2.8 Flu B
1.2.9 Others
1.3 Market Segmentation by Application
1.3.1 Global Respiratory Panel Testing Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Point-of-Care Testing
1.3.3 Laboratories
1.3.4 Hospitals
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Respiratory Panel Testing Revenue Estimates and Forecasts 2020-2031
2.2 Global Respiratory Panel Testing Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Respiratory Panel Testing Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Respiratory Panel Testing Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Adenovirus Market Size by Players
3.3.2 RSV Market Size by Players
3.3.3 Human Metapneumovirus Market Size by Players
3.3.4 Rhinovirus/Enterovirus Market Size by Players
3.3.5 Flu A Market Size by Players
3.3.6 Coronavirus Market Size by Players
3.3.7 Flu B Market Size by Players
3.3.8 Others Market Size by Players
3.4 Global Respiratory Panel Testing Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Respiratory Panel Testing Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Respiratory Panel Testing Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Respiratory Panel Testing Market Size by Type (2020-2031)
6.4 North America Respiratory Panel Testing Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Respiratory Panel Testing Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Respiratory Panel Testing Market Size by Type (2020-2031)
7.4 Europe Respiratory Panel Testing Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Respiratory Panel Testing Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Respiratory Panel Testing Market Size by Type (2020-2031)
8.4 Asia-Pacific Respiratory Panel Testing Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Respiratory Panel Testing Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Respiratory Panel Testing Market Size by Type (2020-2031)
9.4 Central and South America Respiratory Panel Testing Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Respiratory Panel Testing Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Respiratory Panel Testing Market Size by Type (2020-2031)
10.4 Middle East and Africa Respiratory Panel Testing Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Respiratory Panel Testing Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 F. Hoffmann-La Roche Ltd.
11.1.1 F. Hoffmann-La Roche Ltd. Corporation Information
11.1.2 F. Hoffmann-La Roche Ltd. Business Overview
11.1.3 F. Hoffmann-La Roche Ltd. Respiratory Panel Testing Product Features and Attributes
11.1.4 F. Hoffmann-La Roche Ltd. Respiratory Panel Testing Revenue and Gross Margin (2020-2025)
11.1.5 F. Hoffmann-La Roche Ltd. Respiratory Panel Testing Revenue by Product in 2024
11.1.6 F. Hoffmann-La Roche Ltd. Respiratory Panel Testing Revenue by Application in 2024
11.1.7 F. Hoffmann-La Roche Ltd. Respiratory Panel Testing Revenue by Geographic Area in 2024
11.1.8 F. Hoffmann-La Roche Ltd. Respiratory Panel Testing SWOT Analysis
11.1.9 F. Hoffmann-La Roche Ltd. Recent Developments
11.2 bioMerieux SA
11.2.1 bioMerieux SA Corporation Information
11.2.2 bioMerieux SA Business Overview
11.2.3 bioMerieux SA Respiratory Panel Testing Product Features and Attributes
11.2.4 bioMerieux SA Respiratory Panel Testing Revenue and Gross Margin (2020-2025)
11.2.5 bioMerieux SA Respiratory Panel Testing Revenue by Product in 2024
11.2.6 bioMerieux SA Respiratory Panel Testing Revenue by Application in 2024
11.2.7 bioMerieux SA Respiratory Panel Testing Revenue by Geographic Area in 2024
11.2.8 bioMerieux SA Respiratory Panel Testing SWOT Analysis
11.2.9 bioMerieux SA Recent Developments
11.3 Medline Industries, Inc.
11.3.1 Medline Industries, Inc. Corporation Information
11.3.2 Medline Industries, Inc. Business Overview
11.3.3 Medline Industries, Inc. Respiratory Panel Testing Product Features and Attributes
11.3.4 Medline Industries, Inc. Respiratory Panel Testing Revenue and Gross Margin (2020-2025)
11.3.5 Medline Industries, Inc. Respiratory Panel Testing Revenue by Product in 2024
11.3.6 Medline Industries, Inc. Respiratory Panel Testing Revenue by Application in 2024
11.3.7 Medline Industries, Inc. Respiratory Panel Testing Revenue by Geographic Area in 2024
11.3.8 Medline Industries, Inc. Respiratory Panel Testing SWOT Analysis
11.3.9 Medline Industries, Inc. Recent Developments
11.4 Becton
11.4.1 Becton Corporation Information
11.4.2 Becton Business Overview
11.4.3 Becton Respiratory Panel Testing Product Features and Attributes
11.4.4 Becton Respiratory Panel Testing Revenue and Gross Margin (2020-2025)
11.4.5 Becton Respiratory Panel Testing Revenue by Product in 2024
11.4.6 Becton Respiratory Panel Testing Revenue by Application in 2024
11.4.7 Becton Respiratory Panel Testing Revenue by Geographic Area in 2024
11.4.8 Becton Respiratory Panel Testing SWOT Analysis
11.4.9 Becton Recent Developments
11.5 Dickinson & Company
11.5.1 Dickinson & Company Corporation Information
11.5.2 Dickinson & Company Business Overview
11.5.3 Dickinson & Company Respiratory Panel Testing Product Features and Attributes
11.5.4 Dickinson & Company Respiratory Panel Testing Revenue and Gross Margin (2020-2025)
11.5.5 Dickinson & Company Respiratory Panel Testing Revenue by Product in 2024
11.5.6 Dickinson & Company Respiratory Panel Testing Revenue by Application in 2024
11.5.7 Dickinson & Company Respiratory Panel Testing Revenue by Geographic Area in 2024
11.5.8 Dickinson & Company Respiratory Panel Testing SWOT Analysis
11.5.9 Dickinson & Company Recent Developments
11.6 altona Diagnostics GmbH
11.6.1 altona Diagnostics GmbH Corporation Information
11.6.2 altona Diagnostics GmbH Business Overview
11.6.3 altona Diagnostics GmbH Respiratory Panel Testing Product Features and Attributes
11.6.4 altona Diagnostics GmbH Respiratory Panel Testing Revenue and Gross Margin (2020-2025)
11.6.5 altona Diagnostics GmbH Recent Developments
11.7 CerTest Biotec S.L.
11.7.1 CerTest Biotec S.L. Corporation Information
11.7.2 CerTest Biotec S.L. Business Overview
11.7.3 CerTest Biotec S.L. Respiratory Panel Testing Product Features and Attributes
11.7.4 CerTest Biotec S.L. Respiratory Panel Testing Revenue and Gross Margin (2020-2025)
11.7.5 CerTest Biotec S.L. Recent Developments
11.8 Anatolia Geneworks
11.8.1 Anatolia Geneworks Corporation Information
11.8.2 Anatolia Geneworks Business Overview
11.8.3 Anatolia Geneworks Respiratory Panel Testing Product Features and Attributes
11.8.4 Anatolia Geneworks Respiratory Panel Testing Revenue and Gross Margin (2020-2025)
11.8.5 Anatolia Geneworks Recent Developments
11.9 Seegene, Inc.
11.9.1 Seegene, Inc. Corporation Information
11.9.2 Seegene, Inc. Business Overview
11.9.3 Seegene, Inc. Respiratory Panel Testing Product Features and Attributes
11.9.4 Seegene, Inc. Respiratory Panel Testing Revenue and Gross Margin (2020-2025)
11.9.5 Seegene, Inc. Recent Developments
11.10 DiaSorin S.p.A. (Luminex)
11.10.1 DiaSorin S.p.A. (Luminex) Corporation Information
11.10.2 DiaSorin S.p.A. (Luminex) Business Overview
11.10.3 DiaSorin S.p.A. (Luminex) Respiratory Panel Testing Product Features and Attributes
11.10.4 DiaSorin S.p.A. (Luminex) Respiratory Panel Testing Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 QIAGEN
11.11.1 QIAGEN Corporation Information
11.11.2 QIAGEN Business Overview
11.11.3 QIAGEN Respiratory Panel Testing Product Features and Attributes
11.11.4 QIAGEN Respiratory Panel Testing Revenue and Gross Margin (2020-2025)
11.11.5 QIAGEN Recent Developments
11.12 Biocartis
11.12.1 Biocartis Corporation Information
11.12.2 Biocartis Business Overview
11.12.3 Biocartis Respiratory Panel Testing Product Features and Attributes
11.12.4 Biocartis Respiratory Panel Testing Revenue and Gross Margin (2020-2025)
11.12.5 Biocartis Recent Developments
12 Respiratory Panel TestingIndustry Chain Analysis
12.1 Respiratory Panel Testing Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Respiratory Panel Testing Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Respiratory Panel Testing Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Respiratory Panel Testing Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Respiratory Panel Testing Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Respiratory Panel Testing Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Respiratory Panel Testing Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Respiratory Panel Testing Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Respiratory Panel Testing Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Respiratory Panel Testing Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Respiratory Panel Testing by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Panel Testing as of 2024)
Table 11. Global Respiratory Panel Testing Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Respiratory Panel Testing Companies Headquarters
Table 13. Global Respiratory Panel Testing Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Respiratory Panel Testing Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Respiratory Panel Testing Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Respiratory Panel Testing Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Respiratory Panel Testing Revenue by Application (2026-2031) & (US$ Million)
Table 21. Respiratory Panel Testing High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Respiratory Panel Testing Growth Accelerators and Market Barriers
Table 25. North America Respiratory Panel Testing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Respiratory Panel Testing Growth Accelerators and Market Barriers
Table 27. Europe Respiratory Panel Testing Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Respiratory Panel Testing Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Respiratory Panel Testing Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Respiratory Panel Testing Investment Opportunities and Key Challenges
Table 31. Central and South America Respiratory Panel Testing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Respiratory Panel Testing Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Respiratory Panel Testing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. F. Hoffmann-La Roche Ltd. Corporation Information
Table 35. F. Hoffmann-La Roche Ltd. Description and Major Businesses
Table 36. F. Hoffmann-La Roche Ltd. Product Features and Attributes
Table 37. F. Hoffmann-La Roche Ltd. Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. F. Hoffmann-La Roche Ltd. Revenue Proportion by Product in 2024
Table 39. F. Hoffmann-La Roche Ltd. Revenue Proportion by Application in 2024
Table 40. F. Hoffmann-La Roche Ltd. Revenue Proportion by Geographic Area in 2024
Table 41. F. Hoffmann-La Roche Ltd. Respiratory Panel Testing SWOT Analysis
Table 42. F. Hoffmann-La Roche Ltd. Recent Developments
Table 43. bioMerieux SA Corporation Information
Table 44. bioMerieux SA Description and Major Businesses
Table 45. bioMerieux SA Product Features and Attributes
Table 46. bioMerieux SA Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. bioMerieux SA Revenue Proportion by Product in 2024
Table 48. bioMerieux SA Revenue Proportion by Application in 2024
Table 49. bioMerieux SA Revenue Proportion by Geographic Area in 2024
Table 50. bioMerieux SA Respiratory Panel Testing SWOT Analysis
Table 51. bioMerieux SA Recent Developments
Table 52. Medline Industries, Inc. Corporation Information
Table 53. Medline Industries, Inc. Description and Major Businesses
Table 54. Medline Industries, Inc. Product Features and Attributes
Table 55. Medline Industries, Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Medline Industries, Inc. Revenue Proportion by Product in 2024
Table 57. Medline Industries, Inc. Revenue Proportion by Application in 2024
Table 58. Medline Industries, Inc. Revenue Proportion by Geographic Area in 2024
Table 59. Medline Industries, Inc. Respiratory Panel Testing SWOT Analysis
Table 60. Medline Industries, Inc. Recent Developments
Table 61. Becton Corporation Information
Table 62. Becton Description and Major Businesses
Table 63. Becton Product Features and Attributes
Table 64. Becton Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Becton Revenue Proportion by Product in 2024
Table 66. Becton Revenue Proportion by Application in 2024
Table 67. Becton Revenue Proportion by Geographic Area in 2024
Table 68. Becton Respiratory Panel Testing SWOT Analysis
Table 69. Becton Recent Developments
Table 70. Dickinson & Company Corporation Information
Table 71. Dickinson & Company Description and Major Businesses
Table 72. Dickinson & Company Product Features and Attributes
Table 73. Dickinson & Company Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Dickinson & Company Revenue Proportion by Product in 2024
Table 75. Dickinson & Company Revenue Proportion by Application in 2024
Table 76. Dickinson & Company Revenue Proportion by Geographic Area in 2024
Table 77. Dickinson & Company Respiratory Panel Testing SWOT Analysis
Table 78. Dickinson & Company Recent Developments
Table 79. altona Diagnostics GmbH Corporation Information
Table 80. altona Diagnostics GmbH Description and Major Businesses
Table 81. altona Diagnostics GmbH Product Features and Attributes
Table 82. altona Diagnostics GmbH Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. altona Diagnostics GmbH Recent Developments
Table 84. CerTest Biotec S.L. Corporation Information
Table 85. CerTest Biotec S.L. Description and Major Businesses
Table 86. CerTest Biotec S.L. Product Features and Attributes
Table 87. CerTest Biotec S.L. Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. CerTest Biotec S.L. Recent Developments
Table 89. Anatolia Geneworks Corporation Information
Table 90. Anatolia Geneworks Description and Major Businesses
Table 91. Anatolia Geneworks Product Features and Attributes
Table 92. Anatolia Geneworks Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Anatolia Geneworks Recent Developments
Table 94. Seegene, Inc. Corporation Information
Table 95. Seegene, Inc. Description and Major Businesses
Table 96. Seegene, Inc. Product Features and Attributes
Table 97. Seegene, Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Seegene, Inc. Recent Developments
Table 99. DiaSorin S.p.A. (Luminex) Corporation Information
Table 100. DiaSorin S.p.A. (Luminex) Description and Major Businesses
Table 101. DiaSorin S.p.A. (Luminex) Product Features and Attributes
Table 102. DiaSorin S.p.A. (Luminex) Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. DiaSorin S.p.A. (Luminex) Recent Developments
Table 104. QIAGEN Corporation Information
Table 105. QIAGEN Description and Major Businesses
Table 106. QIAGEN Product Features and Attributes
Table 107. QIAGEN Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. QIAGEN Recent Developments
Table 109. Biocartis Corporation Information
Table 110. Biocartis Description and Major Businesses
Table 111. Biocartis Product Features and Attributes
Table 112. Biocartis Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. Biocartis Recent Developments
Table 114. Raw Materials Key Suppliers
Table 115. Distributors List
Table 116. Market Trends and Market Evolution
Table 117. Market Drivers and Opportunities
Table 118. Market Challenges, Risks, and Restraints
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Respiratory Panel Testing Product Picture
Figure 2. Global Respiratory Panel Testing Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Adenovirus Product Picture
Figure 4. RSV Product Picture
Figure 5. Human Metapneumovirus Product Picture
Figure 6. Rhinovirus/Enterovirus Product Picture
Figure 7. Flu A Product Picture
Figure 8. Coronavirus Product Picture
Figure 9. Flu B Product Picture
Figure 10. Others Product Picture
Figure 11. Global Respiratory Panel Testing Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 12. Point-of-Care Testing
Figure 13. Laboratories
Figure 14. Hospitals
Figure 15. Others
Figure 16. Respiratory Panel Testing Report Years Considered
Figure 17. Global Respiratory Panel Testing Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Respiratory Panel Testing Revenue (2020-2031) & (US$ Million)
Figure 19. Global Respiratory Panel Testing Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 20. Global Respiratory Panel Testing Revenue Market Share by Region (2020-2031)
Figure 21. Global Respiratory Panel Testing Revenue Market Share Ranking (2024)
Figure 22. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 23. Adenovirus Revenue Market Share by Player in 2024
Figure 24. RSV Revenue Market Share by Player in 2024
Figure 25. Human Metapneumovirus Revenue Market Share by Player in 2024
Figure 26. Rhinovirus/Enterovirus Revenue Market Share by Player in 2024
Figure 27. Flu A Revenue Market Share by Player in 2024
Figure 28. Coronavirus Revenue Market Share by Player in 2024
Figure 29. Flu B Revenue Market Share by Player in 2024
Figure 30. Others Revenue Market Share by Player in 2024
Figure 31. Global Respiratory Panel Testing Revenue Market Share by Type (2020-2031)
Figure 32. Global Respiratory Panel Testing Revenue Market Share by Application (2020-2031)
Figure 33. North America Respiratory Panel Testing Revenue YoY (2020-2031) & (US$ Million)
Figure 34. North America Top 5 Players Respiratory Panel Testing Revenue (US$ Million) in 2024
Figure 35. North America Respiratory Panel Testing Revenue (US$ Million) by Type (2020 - 2031)
Figure 36. North America Respiratory Panel Testing Revenue (US$ Million) by Application (2020-2031)
Figure 37. US Respiratory Panel Testing Revenue (2020-2031) & (US$ Million)
Figure 38. Canada Respiratory Panel Testing Revenue (2020-2031) & (US$ Million)
Figure 39. Mexico Respiratory Panel Testing Revenue (2020-2031) & (US$ Million)
Figure 40. Europe Respiratory Panel Testing Revenue YoY (2020-2031) & (US$ Million)
Figure 41. Europe Top 5 Players Respiratory Panel Testing Revenue (US$ Million) in 2024
Figure 42. Europe Respiratory Panel Testing Revenue (US$ Million) by Type (2020-2031)
Figure 43. Europe Respiratory Panel Testing Revenue (US$ Million) by Application (2020-2031)
Figure 44. Germany Respiratory Panel Testing Revenue (2020-2031) & (US$ Million)
Figure 45. France Respiratory Panel Testing Revenue (2020-2031) & (US$ Million)
Figure 46. U.K. Respiratory Panel Testing Revenue (2020-2031) & (US$ Million)
Figure 47. Italy Respiratory Panel Testing Revenue (2020-2031) & (US$ Million)
Figure 48. Russia Respiratory Panel Testing Revenue (2020-2031) & (US$ Million)
Figure 49. Asia-Pacific Respiratory Panel Testing Revenue YoY (2020-2031) & (US$ Million)
Figure 50. Asia-Pacific Top 8 Players Respiratory Panel Testing Revenue (US$ Million) in 2024
Figure 51. Asia-Pacific Respiratory Panel Testing Revenue (US$ Million) by Type (2020-2031)
Figure 52. Asia-Pacific Respiratory Panel Testing Revenue (US$ Million) by Application (2020-2031)
Figure 53. Indonesia Respiratory Panel Testing Revenue (2020-2031) & (US$ Million)
Figure 54. Japan Respiratory Panel Testing Revenue (2020-2031) & (US$ Million)
Figure 55. South Korea Respiratory Panel Testing Revenue (2020-2031) & (US$ Million)
Figure 56. Australia Respiratory Panel Testing Revenue (2020-2031) & (US$ Million)
Figure 57. India Respiratory Panel Testing Revenue (2020-2031) & (US$ Million)
Figure 58. Indonesia Respiratory Panel Testing Revenue (2020-2031) & (US$ Million)
Figure 59. Vietnam Respiratory Panel Testing Revenue (2020-2031) & (US$ Million)
Figure 60. Malaysia Respiratory Panel Testing Revenue (2020-2031) & (US$ Million)
Figure 61. Philippines Respiratory Panel Testing Revenue (2020-2031) & (US$ Million)
Figure 62. Singapore Respiratory Panel Testing Revenue (2020-2031) & (US$ Million)
Figure 63. Central and South America Respiratory Panel Testing Revenue YoY (2020-2031) & (US$ Million)
Figure 64. Central and South America Top 5 Players Respiratory Panel Testing Revenue (US$ Million) in 2024
Figure 65. Central and South America Respiratory Panel Testing Revenue (US$ Million) by Type (2020-2031)
Figure 66. Central and South America Respiratory Panel Testing Revenue (US$ Million) by Application (2020-2031)
Figure 67. Brazil Respiratory Panel Testing Revenue (2020-2025) & (US$ Million)
Figure 68. Argentina Respiratory Panel Testing Revenue (2020-2025) & (US$ Million)
Figure 69. Middle East and Africa Respiratory Panel Testing Revenue YoY (2020-2031) & (US$ Million)
Figure 70. Middle East and Africa Top 5 Players Respiratory Panel Testing Revenue (US$ Million) in 2024
Figure 71. South America Respiratory Panel Testing Revenue (US$ Million) by Type (2020-2031)
Figure 72. Middle East and Africa Respiratory Panel Testing Revenue (US$ Million) by Application (2020-2031)
Figure 73. GCC Countries Respiratory Panel Testing Revenue (2020-2025) & (US$ Million)
Figure 74. Israel Respiratory Panel Testing Revenue (2020-2025) & (US$ Million)
Figure 75. Egypt Respiratory Panel Testing Revenue (2020-2025) & (US$ Million)
Figure 76. South Africa Respiratory Panel Testing Revenue (2020-2025) & (US$ Million)
Figure 77. Respiratory Panel Testing Industry Chain Mapping
Figure 78. Channels of Distribution (Direct Vs Distribution)
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Respiratory Panel Testing market?
The top companies in the global Respiratory Panel Testing market are F. Hoffmann-La Roche Ltd.、bioMerieux SA、Medline Industries, Inc..
Related Reports
Respiratory Panel Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Respiratory Panel Testing was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 112
USD 3950.00
(Single User License)
Global Respiratory Panel Testing Market Research Report 2026
The global Respiratory Panel Testing market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-19
Pages: 119
USD 2900.00
(Single User License)
Global Respiratory Panel Testing Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Respiratory Panel Testing market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-16
Pages: 98
USD 4250.00
(Single User License)
Respiratory Panel Testing- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Respiratory Panel Testing was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-07
Pages: 101
USD 3950.00
(Single User License)
Global Respiratory Panel Testing Market Research Report 2025
The global market for Respiratory Panel Testing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-07
Pages: 81
USD 2900.00
(Single User License)
Global Respiratory Panel Testing Market Insights, Forecast to 2030
Market Analysis and Insights: Global Respiratory Panel Testing Market
Published Date: 2024-04-11
Pages: 105
USD 4900.00
(Single User License)
Global Respiratory Panel Testing Market Research Report 2024
The global Respiratory Panel Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-17
Pages: 80
USD 2900.00
(Single User License)
Respiratory Panel Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Respiratory Panel Testing was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-07
Pages: 109
USD 3950.00
(Single User License)
Respiratory Panel Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Respiratory Panel Testing was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 112
USD 3950.00 (Single User License)Global Respiratory Panel Testing Market Research Report 2026
The global Respiratory Panel Testing market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-19
Pages: 119
USD 2900.00 (Single User License)Global Respiratory Panel Testing Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Respiratory Panel Testing market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-16
Pages: 98
USD 4250.00 (Single User License)Respiratory Panel Testing- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Respiratory Panel Testing was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-07
Pages: 101
USD 3950.00 (Single User License)Global Respiratory Panel Testing Market Research Report 2025
The global market for Respiratory Panel Testing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-07
Pages: 81
USD 2900.00 (Single User License)Global Respiratory Panel Testing Market Insights, Forecast to 2030
Market Analysis and Insights: Global Respiratory Panel Testing Market
Published: 2024-04-11
Pages: 105
USD 4900.00 (Single User License)Global Respiratory Panel Testing Market Research Report 2024
The global Respiratory Panel Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-17
Pages: 80
USD 2900.00 (Single User License)Respiratory Panel Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Respiratory Panel Testing was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-07
Pages: 109
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now